Search

11. COVID-19 antivirals utilization: geographic and demographic patterns of treatment in 2022

Author(s):

Murphy, Stephen J. (Stephen James), author
Samson, Lok Wong, author
Sommers, Benjamin D., author

Publication:

Washington, D.C. : Department of Health and Human Services, Office of the Assistant Secretary for Planning and Evaluation, December 23, 2022

Subject(s):

Antiviral Agents -- therapeutic use
COVID-19 Drug Treatment
Drug Utilization -- statistics & numerical data
State Government
United States

12. Development of monoclonal antibody products targeting SARS-CoV-2 for emergency use authorization: guidance for industry

Publication:

Silver Spring, MD : Center for Drug Evaluation and Research, December 2023

Subject(s):

Antibodies, Monoclonal
COVID-19 Drug Treatment
Drug Approval
Drug Industry
Government Regulation
Legislation, Drug
SARS-CoV-2
United States

13. Special assessment of outpatient treatments for COVID-19: final evidence report and meeting summary

Author(s):

Yeung, Kai, 1981- author
Whittington, Melanie D., author
Beinfeld, Molly, author
Mohammed, Rasheed, author
Wright, Abigail, (Of Institute for Clinical and Economic Review), author
Nhan, Emily, author
Fluetsch, Noemi, author
Richardson, Marina, (Of Institute for Clinical and Economic Review), author
Pearson, Steven D., author

Publication:

[Boston, Massachusetts] : Institute for Clinical and Economic Review, May 10, 2022

Subject(s):

Ambulatory Care
COVID-19 Drug Treatment
Home Infusion Therapy
United States

14. Variation in use of anti-SARS-CoV-2 monoclonal antibody therapies by social vulnerability and urbanicity

Author(s):

Kolbe, Allison, author

Publication:

Washington, DC : Office of the Assistant Secretary for Planning and Evaluation, Office of Science & Data Policy, December 2021

Subject(s):

Antibodies, Monoclonal, Humanized -- therapeutic use
COVID-19 Drug Treatment
Healthcare Disparities
Social Vulnerability
Urban Population
Vulnerable Populations
United States